GPNMB confers risk for Parkinson's disease through interaction with alpha-synuclein. Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, et al. Science 2022;377:eabk0637.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, et al. GPNMB confers risk for Parkinson's disease through interaction with alpha-synuclein. Science 2022;377:eabk0637.
PMID: 35981040